COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Research article
[키워드] 95% CI
acute respiratory syndrome
addition
Admission
admitted to ICU
age
Analysis
Cancer
Cardiopulmonary
Chemotherapy
chronic obstructive
clinical
Clinical characteristics
Clinical outcome
Cohort
cohort study
collaboration
collected
Comorbidities
Comorbidity
composed
consecutive patient
Cooperative
coronavirus
country
Course
COVID-19
COVID-19 diagnosis
COVID-19 in patient
criteria
cross-sectional
death
demographics
died
eight
eligible
epithelial
feature
finding
Follow-up
funding
General population
global pandemic
group
high mortality
high mortality rate
histology
hospitalised
hypertension
ICU admission
increased risk
Infection
intensive care
International
Laboratory
lung cancer
Lung imaging
majority
median age
medical record
Mortality
multicentre
multivariable analysis
multivariable logistic regression
Neoplasms
neuroendocrine
Odds ratio
Older
Older age
outcome
pandemic
Patient
patient data
patients
Patients with cancer
patients with COVID-19
performance status
Pneumonia
pulmonary disease
receiving
reduced
RT-PCR
SARS-CoV-2
Sex
smoker
smoking
smoking status
suggested
susceptible
Symptom
Symptoms
therapeutic options
therapy
Thoracic
Thoracic malignancies
Thoracic malignancy
thought
thymic
Treatment
Tumours
univariable
were measured
WHO
with COVID-19
[DOI] 10.1016/S1470-2045(20)30314-4 [Article Type] Research article
[DOI] 10.1016/S1470-2045(20)30314-4 [Article Type] Research article